In August, the Royal Osteoporosis Society (ROS) released the updated Guidelines for the provision of a clinical bone densitometry service. This is the first revision in ten years since 2015.

One notable change in the new version is the inclusion of “opportunistic case-finding including the use of artificial intelligence software” as a method to identify patients who may need bone density testing. The fact that a guideline issued by such an authoritative society now explicitly recognizes the role of AI in clinical practice marks a significant milestone.

At PROMEDIUS, we have already been developing AI technology that analyzes chest X-rays to support osteoporosis risk screening, helping healthcare professionals identify patients earlier. With this, we aim to capture the golden time for osteoporosis screening, open a new paradigm for fracture prevention, and ultimately realize our mission: Healthy Aging through AI.✨